Dr. Lateef Mohiuddin Khan
My Social Links

Dr. Lateef Mohiuddin Khan

Assistant Professor
King Abdul Aziz University, Saudi Arabia

Highest Degree
M.D. in Pharmacology from King Abdul Aziz University, Madinah, Saudi Arabia

Share this Profile

Biography

Dr. Lateef Mohiuddin Khan is currently working as Assistant Professor at King Abdul Aziz University, Saudi Arabia. He obtained his M.D. in Pharmacology from same University. His main area of interest related to Pharmacology and Toxicology. His area of expertise includes Pharmacology, Clinical Pharmacology, Pharmacovigilance, and Adverse Drug Reactions. He has 4 publications in journals.

Area of Interest:

Pharmacology and Toxicology
100%
Pharmacology
62%
Clinical Pharmacology
90%
Pharmacovigilance
75%
Adverse Drug Reaction
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Osman, A.M.M., H.M. Al-Kreathy, A. Al-Zahrani, O.A. Ahmed and W.S. Ramadan et al., 2017. Enhancement of efficacy and reduced toxicity of cisplatin through Self Nanoemulsifying Drug Delivery System (SNEDDS). Int. J. Pharmacol., 13: 292-302.
    CrossRef  |  Direct Link  |  
  2. Khan, L.M., F.O. Kamel, H.M. Alkreathy, S.E. Al-Harthi, O.I. Saadah, A.M.M. Osman and M.A. Allibaih, 2017. Benefits of medication antidote signals for the detection of potential adverse drug reactions over contemporary methods of pharmacovigilance in hospitalized children. Int. J. Pharmacol., 13: 64-73.
    CrossRef  |  Direct Link  |  
  3. Afify, E.A., H.M. Alkreathy, A.S. Ali, H.A. Alfaifi and L.M. Khan, 2017. Characterization of the antinociceptive mechanisms of Khat extract (Catha edulis) in mice. Front. Neurol., Vol. 8. 10.3389/fneur.2017.00069.
    CrossRef  |  Direct Link  |  
  4. Khan, L.M., S.E. Al-Harthi, A.M.M. Osman, M.A.A.A. Sattar and A.S. Ali, 2016. Dilemmas of the causality assessment tools in the diagnosis of adverse drug reactions. Saudi Pharmaceut. J., 24: 485-493.
    CrossRef  |  Direct Link  |  
  5. Al-Nasser, M.S., A.S. Ali, M.A.A. Sattar, E.H. Abdulfattah, L.M. Khan and K.A. Al-Alsheikh, 2016. Therapeutic Drug Monitoring of Tacrolimus in Saudi Kidney Transplant Patients. J. Nephrol. Ther., 6: 1-5.
    CrossRef  |  
  6. Osman, A.M.M., S.A. Telity, Z.A. Damanhouri, S.E. Al-Harthy and H.M. Al-Kreathy et al., 2015. Chemosensitizing and nephroprotective effect of resveratrol in cisplatin-treated animals. Cancer Cell Int., Vol. 15. 10.1186/s12935-014-0152-2.
    CrossRef  |  Direct Link  |  
  7. Osman, A.M.M., A.A. Ali, Z.A. Damanhouri, S.E. Al-Harthy and M.F. ElShal et al., 2015. Dimethylsulfoxide excerbates cisplatin-induced cytotoxicity in Ehrlich ascites carcinoma cells. Cancer Cell Int., Vol. 15. 10.1186/s12935-015-0258-1.
    CrossRef  |  Direct Link  |  
  8. Khan, L.M., S.E. Al-Harthi, H.M. Alkreathy, A.M.M. Osman and A.S. Ali, 2015. Detection of adverse drug reactions by medication antidote signals and comparison of their sensitivity with common methods of ADR detection. Saudi Pharmaceut. J., 23: 515-522.
    CrossRef  |  Direct Link  |  
  9. Allibaih, M. and L.M. Khan, 2015. Weaving together peer assessment, audios and medical vignettes in teaching medical terms. Int. J. Med. Educ., 6: 172-178.
    CrossRef  |  Direct Link  |  
  10. Al-Zahrani, Y.A., S.E. Al-Harthi, L.M. Khan, H.M. El-Bassossy, S.M. Edris and M.A.A.A. Sattar, 2015. The possible antianginal effect of allopurinol in vasopressin-induced ischemic model in rats. Saudi Pharmaceut. J., 23: 487-498.
    CrossRef  |  Direct Link  |  
  11. Al-Salmi, A.A., M.A. Sattar, L.M. Khan and S.E. Al-Harthi, 2015. Comparative study of analgesic and anti-inflammatory effects of Commiphora opobalsamum with diclofenac in rodents. Afr. J. Pharm. Pharmacol., 9: 806-817.
    Direct Link  |  
  12. Al-Harthi, S.E., L.M. Khan, A.M. Osman, M.A. Alim, O.I. Saadah, A.A. Almohammadi, F.M. Khan and F.O. Kamel, 2015. Perceptions and knowledge regarding antimicrobial stewardship among clinicians in Jeddah, Saudi Arabia. Saudi Med. J., 36: 813-820.
    CrossRef  |  Direct Link  |  
  13. Al-Harthi, S.E., O.M. Alarabi, W.S. Ramadan, M.N. Alaama and H.M. Al-Kreathy et al., 2014. Amelioration of doxorubicin-induced cardiotoxicity by resveratrol. Mol. Med. Rep., 10: 1455-1460.
    CrossRef  |  Direct Link  |  
  14. Khan, L.M., S.E. Al-Harthi and O.I. Saadah, 2013. Adverse drug reactions in hospitalized pediatric patients of saudi arabian university hospital and impact of pharmacovigilance in reporting ADR. Saudi Pharm. J., 21: 261-266.
    CrossRef  |  PubMed  |  Direct Link  |  
  15. Khan, L.M., 2013. Comparative epidemiology of hospital-acquired adverse drug reactions in adults and children and their impact on cost and hospital stay-a systematic review. Eur. J. Clin. Pharmacol., 69: 1985-1996.
    CrossRef  |  PubMed  |  Direct Link  |  
  16. Al-Harthi, S.E., L.M. Khan, H.H. Abed, H.M. Alkreathy and A.S. Ali, 2013. Appraisal of antimicrobial prescribing practices of governmental and non-governmental dentists for hospitals in the western region of Saudi Arabia. Saudi Med. J., 34: 1262-1269.
    PubMed  |  
  17. Khan, L.M., S.E. Al-Harthi, O.I. Saadah, A.B. Al-Amoudi and M.I. Sulaiman et al., 2012. Impact of pharmacovigilance on adverse drug reactions reporting in hospitalized internal medicine patients at Saudi Arabian teaching hospital. Saudi Med. J., 33: 863-868.
    PubMed  |  Direct Link  |